Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Website URL
Similar Companies1000
APC Biotechnology Services, Inc
APC Biotechnology Services is a startup that develops a novel bioprocess platform for synthesizing toxic enzymes in bacteria.
Sector
Subsector
Location
FGen
FGen is a Swiss start-up that optimizes biocatalysts and microbes for biotechnological processes.
Sector
Subsector
Location
total rounds
total raised
Ribbon Biolabs
Ribbon Biolabs is a biotech start-up developing a platform for error-proof DNA synthesis.
Sector
Subsector
Keywords
Location
total rounds
total raised
Novici Biotech
Novici Biotech provides novel technologies for accelerating research in directed evolution and synthetic biology.
Sector
Subsector
Keywords
Location
Financials
Funding Rounds6
Number of Funding Rounds
Money Raised
Their latest funding was raised on 11.04.2022. Their latest investor National Science Foundation. Their latest round Series A
Northpond Ventures
Northpond Ventures is a science-driven venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Horizons Ventures
Horizons Ventures is a Hong Kong-based venture capital firm that invests in disruptive and technology-focused start-ups.
Sector
Subsector
Location
count Of Investments
count Of Exists
Humboldt Fund
The Humboldt Fund invests in early-stage biotech companies.
Sector
Subsector
Keywords
Location
count Of Investments
National Science Foundation
The National Science Foundation (NSF) is an independent federal agency that funds scientific research and education in the United States.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors15
Number of lead investors
Number of investors
National Science Foundation
The National Science Foundation (NSF) is an independent federal agency that funds scientific research and education in the United States.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Y Combinator
Y Combinator is a startup fund and program that invests in a large number of startups twice a year.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
Ischyros New York
Ischyros New York is a multi-strategy hedge fund investing across asset classes.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders2
Daniel Arlow
Dan received his Ph.D. from the University of California, Berkeley for his work in Jay Keasling’s lab developing new technologies for the de novo synthesis of DNA. Previously, he was a Scientific Associate at D.E. Shaw Research, where he studied the biophysical properties of G protein-coupled receptors, including how drugs bind and modulate their activity. Dan began his scientific career at MIT, where he earned dual S.B. degrees in Math with Computer Science and Biology, and developed computation tools for the analysis of the regulation of gene expression in Vamsi Mootha’s lab at the Broad Institute of MIT and Harvard. He has co-authored over 20 scientific publications, including papers in Nature, Science, Cell, PNAS, and Nature Biotechnology that have been cited over 5,000 times in aggregate, and is a co-inventor of two patents.
current job
organization founded
Daniel Arlow
Sebastian Palluk
Sebastian received a Bachelor's degree in Biology and a Master's degree in Biomolecular Engineering from Darmstadt University of Technology. His Master's thesis research was a computational investigation of the compatibility of Terminal Deoxynucleotidyl Transferase (TdT) with reversible Terminator Nucleotides (RTdNTPs) for de novo DNA synthesis. Sebastian joined Lawrence Berkeley Lab's Joint BioEnergy Institute in 2015, where he teamed up with Dan to develop the first demonstration of a practical enzymatic de novo DNA synthesis method, reported in Nature Biotechnology.
current job
organization founded
Sebastian Palluk
Employee Profiles4
Jeremiah Hanes
Senior Vice President of Research & Development
Activity
Recent News4
The graph reveals the ratio (%) of positive news articles in a chosen time range